Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pharmaceutical Vertex and Orna Partner for Innovative Gene Therapy Solutions
gene therapy (1)

Vertex and Orna Partner for Innovative Gene Therapy Solutions

8th January 2025

In a significant advancement for the biopharma industry, Vertex Pharmaceuticals has announced a partnership with Orna Therapeutics to develop cutting-edge in vivo gene editing therapies targeting sickle cell disease and beta thalassaemia. This collaboration aims to leverage Orna’s proprietary lipid nanoparticle technology to potentially revolutionise the treatment process, offering efficient delivery mechanisms that could overcome current therapy limitations.

The venture is a strategic move for Vertex, following its collaboration with CRISPR Therapeutics on Casgevy, a gene therapy recently approved by the FDA for sickle cell and beta thalassaemia. Casgevy’s complex and time-consuming process involves modifying patient stem cells in a laboratory before re-infusing them. Orna’s lipid nanoparticles, however, are engineered to target tissues beyond the liver, presenting a promising alternative that could simplify therapy delivery and reduce treatment time significantly.

The biopharma sector has faced challenges, with investment into cell and gene therapy seeing a decline. Yet, innovations like Vertex and Orna’s partnership offer renewed optimism. If successful, this collaboration could pioneer a new wave of gene therapies that bypass toxic preconditioning and streamline manufacturing processes, positioning Vertex as a leader in advanced therapeutic delivery.

Vertex’s partnership with Orna Therapeutics exemplifies the innovative strides being made in gene therapy. By leveraging Orna’s cutting-edge technology, the alliance aims to transform therapeutic delivery, offering hope for more efficient treatments for sickle cell and beta thalassaemia. Stakeholders in the biopharma industry will be keenly observing this collaboration for its potential to set new benchmarks in gene therapy development.

Contact Marcus for more details.

We have hundreds of jobs available across the Healthcare industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.